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Introduction: Adenocarcinomas represent less than 2 percent of all urothelial neoplasms. Hepatoid
adenocarcinoma is rare in the urinary bladder. Pathological diagnosis is based on a combination of histological
features resembling hepatocellular carcinoma and positive immunostaining for α-fetoprotein.
Case presentation: We report a case of hepatoid adenocarcinoma of the urinary bladder. A 49-year-old Japanese
woman underwent a total mastectomy, and post-operatively abdominal computed tomography revealed a tumor
of the urinary bladder. Trans-urethral resection of the bladder tumor was performed, and pathological examination
revealed a hepatoid adenocarcinoma of the urinary bladder. Our patient has had no evidence of recurrence
20 months after surgery to remove the tumor.
Conclusions: Hepatoid adenocarcinoma seems to be an aggressive malignant neoplasm that is rare in the urinary
bladder. This case report is only the ninth case of hepatoid adenocarcinoma in the urinary bladder to appear in the
literature. It is important to be aware of atypical cancer localizations in order to reach a correct diagnosis.
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Hepatoid adenocarcinoma (HAC) is a very rare finding,
and generally occurs in the stomach, ovaries, and lungs.
The term hepatoid adenocarcinoma was first introduced
by Ishikura et al. in 1985 [1]. This report presents only
the ninth case of HAC in the urinary bladder to be pub-
lished in the literature, and reviews the previously
reported cases.
Case presentation
A 49-year-old Japanese woman was diagnosed as having
a breast tumor, and a total mastectomy was subse-
quently performed. A histology study of the breast
tumor revealed a ductal carcinoma in situ with the
pathological stage TisN0M0. A year after surgery,
abdominal computed tomography (CT) revealed a mass
lesion in the urinary bladder (Figure 1). There were no
abnormal findings in the liver. Serological markers for* Correspondence: akikosekino@gmail.com
1Department of Urology, Miyoshi Central Hospital, 531 Higashisakaya,
Hiroshima Prefecture, Miyoshi, Japan
Full list of author information is available at the end of the article
© 2013 Sekino et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orhepatitis B and C viruses were also within normal limits.
Cystoscopy revealed a solitary tumor on the left wall of
the bladder (Figure 2). The tumor appeared to occur
from the subepithelial tissue. Based on the findings, our
patient was diagnosed as having a bladder tumor, there-
fore trans-urethral resection of the bladder tumor
(TURBT) was performed. The tumor cells were micro-
scopically typed as a hepatocellular carcinoma, featuring
large, polygonal cells with marked nuclear atypia and
eosinophilic granular or clear cytoplasma (Figure 3).
Immunohistochemical staining test results were positive
for α-fetoprotein (AFP) (Figure 4). A histology study of
the tumor revealed a typical HAC, predominantly re-
sembling a hepatocellular carcinoma. The tumor had
spread to the subepithelial connective tissue below the
non-atypical transitional epithelium, and the patho-
logical stage was T1N0M0. After surgery, her serum
AFP concentration was within normal limits. Chemo-
therapy was not administered. At 20 months after sur-
gery, our patient has had no evidence of recurrence.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Abdominal computed tomography showing a 6mm
mass in the bladder.
Figure 3 Histopathological features of hepatoid
adenocarcinoma of the urinary bladder. The tumor was
composed of large, polygonal cells with eosinophilic cytoplasm. The
cells were predominantly arranged in a trabecular pattern
(hematoxylin and eosin stained specimen, ×100).
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HAC is a rare tumor, which is characterized by the mor-
phological phenotype of a hepatocellular carcinoma.
HAC is defined by the reproduction of a pattern similar
to that of a hepatocellular carcinoma, with a combin-
ation of histopathological findings of solid nests and
trabecular structures of polygonal atypical cells with
wide granular cytoplasm and an immunochemical ex-
pression of AFP. Before a diagnosis of HAC is made, the
metastases of a hepatocellular carcinoma should be
ruled out.
Metzgeroth et al. recently published an evaluation of
262 HAC cases [2]. The stomach was the most common
location with a frequency of 63 percent, followed by
the ovaries (10 percent), lungs (4 percent), gallbladderFigure 2 Cystoscopy showing a solitary tumor on the left wall
of the bladder.(3 percent), pancreas (4 percent), uterus (4 percent),
and urinary bladder (3 percent). HAC usually presents
in older patients. The male to female ratio was 2.4:1 and
the median age at diagnosis was 65 years (range 21 to
88 years). HAC is treated like other adenocarcinomas of
the common type, depending on the organ system
involved. The prognosis of HAC is considered to be un-
favorable. HAC is regarded to be an aggressive neo-
plasm associated with a high proportion of metastases
at the time of diagnosis. The lymph nodes, the liver and
the brain are common metastatic sites. The survival rate
of 83 cases with various HAC indicated 43 patients had
died within the first 12 months, and 40 patients wereFigure 4 Immunohistochemical profile of hepatoid
adenocarcinoma of the urinary bladder. Intra-cytoplasmic cells
positive for α-fetoprotein, ×100.










1. Sinard [3] 68/F Hydronephrosis 2.5cm N/A TUR T3a 17 AWD




T2b 1 Lost to follow-up
3. Burgues [5] 71/M Hematuria NA WNL TUR T2 N/A AWD
4. Lopez-Beltran [6] 66/M Hematuria 6×5cm 1065ng/mL Total
cystectomy
T3a 14 Lung metastatsis,
DOD
5. Lopez-Beltran [6] 85/M Hematuria 80g,
resected
N/A TUR T2 12 Lung metastatsis,
DOD
6. Lopez-Beltran [6] 61/M Hematuria 5×5cm 2025ng/mL Total
cystectomy
T3a 19 Lung metastatsis,
DOD
7. Lopez-Beltran [6] 68/M Hematuria 1.5cm 1070ng/mL TUR T1 26 NED
8. Kawamura [7] 79/M Hematuria 1cm 39.08ng/mL TUR Ta 20 NED
9. Present case 49/F - 6mm NA TUR T1 20 NED
AFP = α-fetoprotein; AWD = alive with disease; DOD = died of disease; NED = alive with no evidence of disease; NA = not available; TUR = trans-urethral
resection; WNL = within normal limits.
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rate (expressed as a percentage) was about 55 percent
and the median overall period of survival was 11 months
(range 0 to 102 months) [2].
The first case of HAC in the urinary bladder was
reported by Sinard et al. in 1994 [3] and only eight cases
have been reported to date [3-7]. The main clinical and
pathological data from the previously reported cases are
presented in Table 1 [2-6]. As can be seen from the pre-
vious cases and our patient’s case, the patients were six
men and three women. Their mean age was 68 years
(range: 49 to 89 years). Hematuria was the initial symp-
tom in six patients. Six cases received serum AFP exami-
nations and five yielded positive results. However, HAC
was not always accompanied by high levels of serum
AFP [8]. Three cases were treated with cystectomies and
six with TURBT. The pathological stages were T1 (n=3),
T2 (n=3), and T3 (n=3). The prognosis of HAC was
considered to be unfavorable, like that of other organs.
Three patients underwent cystectomies and died of the
disease 12 to 19 months later due to lung metastases.
However, three cases of pT1 appeared to have been
cured by TURBT and, post-operatively, they have had no
evidence of recurrence more than 20 months later. The
prolonged patient survival might be related to the low
pathological stage of the tumor. Further studies with a
large number of cases are required to classify the risk
and management of HAC in the urinary bladder.Conclusions
Hepatoid adenocarcinoma is a highly aggressive tumor
mimicking the histological appearance of hepatocellular
carcinoma. There are few reports describing hepatoid
adenocarcinoma of the urinary bladder. It is importantto be aware of atypical cancer localizations in order to
reach a correct diagnosis.
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